CN1035860C - 血液磁极化治疗机的充磁充氧装置 - Google Patents
血液磁极化治疗机的充磁充氧装置 Download PDFInfo
- Publication number
- CN1035860C CN1035860C CN93111026A CN93111026A CN1035860C CN 1035860 C CN1035860 C CN 1035860C CN 93111026 A CN93111026 A CN 93111026A CN 93111026 A CN93111026 A CN 93111026A CN 1035860 C CN1035860 C CN 1035860C
- Authority
- CN
- China
- Prior art keywords
- blood
- ultraviolet light
- magnetic polarization
- control circuit
- ball joint
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 210000004369 blood Anatomy 0.000 title claims abstract description 31
- 239000008280 blood Substances 0.000 title claims abstract description 31
- 230000005291 magnetic effect Effects 0.000 title claims abstract description 16
- 230000010287 polarization Effects 0.000 title claims abstract description 11
- 230000001225 therapeutic effect Effects 0.000 title claims description 8
- 230000001706 oxygenating effect Effects 0.000 title 1
- 210000000988 bone and bone Anatomy 0.000 claims description 12
- 229910052760 oxygen Inorganic materials 0.000 claims description 11
- 239000001301 oxygen Substances 0.000 claims description 11
- 239000011435 rock Substances 0.000 claims description 10
- 230000000694 effects Effects 0.000 abstract description 11
- 201000010099 disease Diseases 0.000 abstract description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 7
- 208000026106 cerebrovascular disease Diseases 0.000 abstract description 6
- 208000024172 Cardiovascular disease Diseases 0.000 abstract description 5
- 230000002526 effect on cardiovascular system Effects 0.000 abstract description 5
- 230000004060 metabolic process Effects 0.000 abstract description 5
- 210000004204 blood vessel Anatomy 0.000 abstract description 2
- 230000002411 adverse Effects 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 238000006479 redox reaction Methods 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 210000001772 blood platelet Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 238000006213 oxygenation reaction Methods 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000006722 reduction reaction Methods 0.000 description 2
- 238000005096 rolling process Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 241000406668 Loxodonta cyclotis Species 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 210000003912 basophilic leucocyte Anatomy 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 150000003943 catecholamines Chemical class 0.000 description 1
- 210000005056 cell body Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000004154 complement system Effects 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000005288 electromagnetic effect Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 229940027941 immunoglobulin g Drugs 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 230000005415 magnetization Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 229950001950 ocrase Drugs 0.000 description 1
- 108010006055 ocrase Proteins 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- WURFKUQACINBSI-UHFFFAOYSA-M ozonide Chemical compound [O]O[O-] WURFKUQACINBSI-UHFFFAOYSA-M 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 230000005298 paramagnetic effect Effects 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 238000006552 photochemical reaction Methods 0.000 description 1
- 238000006303 photolysis reaction Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 230000004218 vascular function Effects 0.000 description 1
Images
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Radiation-Therapy Devices (AREA)
Abstract
本发明涉及治疗心脑血管病的医疗设备，它和控制电路一起构成血液磁极化医疗机。本发明主要是由定、动磁铁、紫外光管及其传感器和晃动机构组成，它在控制电路的控制下，静脉血液在晃动磁场中充磁，在紫外线下充氧，达到净化血液，促进新陈代谢，改善血管功能。它能治疗心脑血管等多种疾病，特别适合老年病，并几乎无毒副作用。
摘要附图选用图1。
Description
本发明涉及治疗心脑血管病的医疗设备，特别是对静脉血充磁充氧的一种医疗设备。
我国目前的医学诊断仪器、技术已基本达到与世界同步水平，而医学治疗设备及技术与世界先进国家相比差近20年水平，尤其是在中老年疾病的治疗方面更为突出。由于我国部分发达地区近几年才步入老年社会行列，所以对老年医学、保健系统研究还处于起步阶段。可是，老年病、特别是心脑血管病、代谢性疾病的发病率、患病率和死亡率在逐年大幅度提高，心脑血管病的死亡率和致残率已越居第一位。由于心脑血管病的高致残率不但给患者本人带来极大痛苦，也给家庭和社会增加了沉重的负担。
当前，医治上述老年病的方法虽然很多，但是能够从根本上解决致残、复发的方法却显得太少，加之药物的毒副作用和耐受性使老年病的治疗更加困难。
本发明的目的是提供一种血液磁极化治疗机的充磁充氧装置，该装置和控制电路一起，构成血液磁极化治疗机，该装置在控制电路的控制下，可以对静脉血液充磁充氧，达到净化血液、促进新陈代谢、改善血管功能的作用，又可唤醒、修复衰老和受损的组织，通过磁极化作用理顺细胞分子间的正常磁极排列秩序，并克服了药物治疗的毒副作用。
下面介绍本发明：
1、血液极化治疗机的充磁充氧装置的结构
机架的最上端固定磁铁，称为定磁铁，磁铁的下端有紫外光传感器，传感器的下端是可晃动的骨支架，在骨支架上，自上而下装有血样瓶、紫外光管和磁铁，因该磁铁随骨支架晃动，故称动磁铁。定磁铁与动磁铁之间形成晃动磁场。紫外光传感器接收紫外灯管发射的紫外光，并能转换成电信号送给控制电路，晃动骨支架的下端连支撑杆，支撑杆的下端连万向球节，该万向球节在凹面球套里，球套固定在机架上，万向球节下的连杆，固定在偏心轮上，偏心轮靠电机驱动，电机受控制电路的控制。本发明的工作原理是；将患者的静脉血，装入血样瓶中，在磁场中充磁，并通过磁极化作用理顺血液细胞分子间的正常磁极排列秩序。同时紫外灯管通过驱动器接到微电脑的输出端，紫外灯管在这个控制电路的控制下，发出特定波长的紫外光线，对血液进行辐射、充氧，紫外线传感器接收紫外光，该传感器依次通过光敏采样电路和比较放大电路接到微电脑的输入端，将接收的紫外光，转换成电信号，微电脑接此信号后进行分析判断，如能达到正常规定的要求，微电脑的输出端通过驱动器，接到电机上，命令电机作正、反方向旋转，依次通过偏心轮、球节、支撑杆，带动骨支架往返晃动。
2、治疗原理
大量临床实践证明，人类百余种疾病是与血液成份改变和血液源变学改变有关。血液磁极化治疗机是将患病的血液置于一特定的磁场中，在磁场的作用下，经特定波长紫外光量子辐照，同时充以高浓度氧气，使其发生光电磁效应，光化学反应和磁化、光解、感光异构及组织、器官高性能氧化一还原反应，并能产生灭活细菌和病毒等微生物在人体产生的毒素，兴奋免疫系统，提高和增强机体的抗感染能力和平衡机体体液免疫，迅速升高免疫球蛋白G的水平，激活补体系统，增加血氧分压，调节新陈代谢和改善微循环系统的效能。
血液在本机治疗期间，白细胞总数上升，吞噬活性增加50％。经几次治疗后，嗜碱细胞显著上升，释放大量肝素，组织胺、儿茶酚胺和血胰蛋白酶等脂酶物质；抑制凝血作用，降低纤维蛋白原水平，活跃间质的新陈代谢。同时在治疗期间T淋巴细胞明显增多，红细胞数量上升，血红蛋白与氧结合能力增强，血小板降低，血沉变慢，血液粘滞度下降，血小板与细胞聚集性降低，胆固醇浓度降低，纤维溶解酶被活化，血管壁的状态被改善。由于血液充磁而使红细胞表面大量的游离状态的顺磁物质负电荷增加，细胞相互间的静电斥力增加，聚集性减少，改善了血液流变学。同时高浓度氧吸收紫外光能量产生臭氧，臭氧与不饱合脂肪酸反应产生臭氧化合物。这些物质犹如高性能氧化物与血红蛋白反应，在体内迅速引起氧化—还原反应，并可作为内源性过氧化酶起到恒定的内源性氧化作用，参与人体组织的氧化—还原反应，促进能量合成，调节新陈代谢，改善微循环和氧利用的保护功能。
本发明与控制电路一起构成的治疗机，同现有技术相比，具有以下特点：
1、应用范围广：它可应用于神经科、内科、心血管科、外科、妇产科、儿科、口腔科、肿瘤科，尤其对中老年患者，一身患有多种疾病，用本治疗机可以从根本上恢复健康。
2、几乎无毒副作用。
3、疗效好，疗程短。
4、操作简单，自动化程度高，治疗质量高。
下面结合附图进一步说本发明。
图1是本发明的结构示意图。
图2是控制本发明的控制电路的电原理框图。
参见图1，机架14的最上端固定永久磁铁1，称为定磁铁1，磁铁的下端有紫外光传感器2，传感器的下端是可晃动的骨支架7，在骨支架上，自上而下装有血样瓶4、紫外光管5和永久磁铁6，因该磁铁随骨支架晃动，故称动磁铁6。定磁铁与动磁铁之间形成晃动磁场。紫外光传感器接收紫外灯管发射的紫外光，并能转换成电信号送给控制电路，晃动骨支架的下端连支撑杆13，支撑杆的下端连万向球节9，该万向球节在凹面球套8里，球套固定在机架14上，万向球节下的连杆12，固定在偏心轮10上，偏心轮靠电机11驱动。电机受控制电路的控制。本发明的工作原理是：将患者的静脉血，装入血样瓶中，在磁场中充磁，并通过磁极化作用理顺血液细胞分子间的正常磁极排列秩序。同时紫外灯管通过驱动器接到微电脑的输出端，紫外灯管在这个控制电路的控制下，发出特定波长的紫外光线，对血液进行辐射、充氧，紫外线传感器接收紫外光，该传感器依次通过光敏采样电路和比较放大电路接到微电脑的输入端，将接收的紫外光，转换成电信号，微电脑接此信号后进行分析判断，如能达到正常规定的要求，微电脑的输出端通过驱动器，接到电机上，命令电机作正、反方向旋转，依次通过偏心轮、球节、支撑杆，带动骨支架往返晃动。
在晃动骨支架上端边缘，有血样瓶卡子3，用来固定血样瓶。
Claims (1)
1、血液磁极化治疗机的充磁充氧装置，由紫外光传感器、血样瓶、紫外光管、磁场和传动装置组成，其特征是：所述的传动装置为；晃动骨支架的下端连支撑杆，支撑杆的下端连万向球节，该万向球节在凹面球套里，球套固定在机架上，万向球节下的连杆，固定在偏心轮上，偏心轮靠电机驱动，电机受控制电路的控制。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN93111026A CN1035860C (zh) | 1993-04-06 | 1993-04-06 | 血液磁极化治疗机的充磁充氧装置 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN93111026A CN1035860C (zh) | 1993-04-06 | 1993-04-06 | 血液磁极化治疗机的充磁充氧装置 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1093599A CN1093599A (zh) | 1994-10-19 |
| CN1035860C true CN1035860C (zh) | 1997-09-17 |
Family
ID=4988835
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN93111026A Expired - Fee Related CN1035860C (zh) | 1993-04-06 | 1993-04-06 | 血液磁极化治疗机的充磁充氧装置 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1035860C (zh) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105641765B (zh) * | 2016-03-09 | 2017-10-27 | 江苏能瑞环保节能科技有限公司 | 用于血透机的血液小分子团化处理器 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN2048364U (zh) * | 1988-12-21 | 1989-11-29 | 中国人民解放军第260医院 | 血液辐射治疗仪 |
| CN1065798A (zh) * | 1992-02-19 | 1992-11-04 | 刘广凯 | 血液离子治疗仪 |
| CN2127019Y (zh) * | 1992-06-27 | 1993-02-17 | 石家庄市华行医疗器械厂 | 血液辐射治疗仪的新型旋摆机构 |
-
1993
- 1993-04-06 CN CN93111026A patent/CN1035860C/zh not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN2048364U (zh) * | 1988-12-21 | 1989-11-29 | 中国人民解放军第260医院 | 血液辐射治疗仪 |
| CN1065798A (zh) * | 1992-02-19 | 1992-11-04 | 刘广凯 | 血液离子治疗仪 |
| CN2127019Y (zh) * | 1992-06-27 | 1993-02-17 | 石家庄市华行医疗器械厂 | 血液辐射治疗仪的新型旋摆机构 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1093599A (zh) | 1994-10-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO1995004572A1 (fr) | Procede de magnetotherapie et dispositif magnetique de balayage a champ magnetique | |
| Ament | Diagnosis and treatment of giardiasis | |
| ATE99544T1 (de) | Liposomale radiologische kontrastmittel. | |
| DE3782498D1 (de) | Verwendung von granulozyt-makrophagen-kolonie erregenden faktor zur herstellung eines medikaments zur behandlung von bakterieller krankheiten. | |
| CN1035860C (zh) | 血液磁极化治疗机的充磁充氧装置 | |
| CN103083362B (zh) | 一种多用途功能水及其制备方法 | |
| CN1037664C (zh) | 一种磁场扫描式理疗机 | |
| CN1123050C (zh) | 改善皮肤状况的方法 | |
| CN2438454Y (zh) | 多功能血液治疗仪 | |
| Yan et al. | A new DNA immune adsorbent for hemoperfusion in SLE therapy: a clinical trial | |
| CN1136923C (zh) | 血磁机动磁场的充磁装置 | |
| Wilson et al. | Evidence for a toxic substance of bacterial origin in the blood of irradiated mice | |
| Bakkeren et al. | Phytohaemagglutinin stimulation of peripheral lymphocytes in children with acute lymphoblastic leukaemia during remission | |
| CN2475407Y (zh) | 血磁机动磁场的充磁装置 | |
| CN2734209Y (zh) | 多疗法医疗保健罐 | |
| CN215608843U (zh) | 一种新型理疗仪的坐式结构 | |
| CN1022733C (zh) | 负压磁性保健治疗拔罐 | |
| CN2063018U (zh) | 管式血疗机 | |
| CN101332319A (zh) | 一种血液治疗仪用的过滤机构 | |
| CN2568199Y (zh) | U型石英管输液器 | |
| CN1330958A (zh) | 磁化量子血液处理装置 | |
| CN2353385Y (zh) | 磁极化光辐照血疗仪 | |
| CN2126572Y (zh) | 强力药液磁化器 | |
| SU1162435A1 (ru) | Способ лечени стафилококкового сепсиса | |
| SU1673115A1 (ru) | Способ лечени рецидивирующего бронхита у детей |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: DONGDA BLOOD MAGNET TECHNOLOGY DEVELOPMENT CO., L Free format text: FORMER OWNER: ZHANG XINGDONG Effective date: 20030620 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20030620 Address after: 110179 Liaoning Province, Shenyang high tech Industrial Zone in Hunnan Road No. 1 building A room 1604 Patentee after: Shenyang Dongda blood magnetic technology development Limited by Share Ltd Address before: 110015 No. 105 Changqing street, Dongling District, Liaoning, Shenyang Patentee before: Zhang Xingdong |
|
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |